The medical management of masseteric hypertrophy with botulinum toxin type A
- PMID: 8136334
- DOI: 10.1016/0266-4356(94)90168-6
The medical management of masseteric hypertrophy with botulinum toxin type A
Abstract
We describe the successful outpatient medical treatment of a patient with bilateral masseteric hypertrophy using botulinum toxin type A in a double-blind placebo controlled study. No significant side-effects occurred, and benefit has so far lasted for 6 months.